Global Times: China's ability to translate long-term strategy into implementation a material asset
BEIJING, May 26, 2026 /PRNewswire/ -- 2026 marks the commencement of China's 15th Five-Year Plan (2026-30), a pivotal phase in the nation's medium- to long-term development. A successful venture starts with a good plan and with clear goals set. At...
Ractigen Therapeutics Doses First Patient in IIT Study of RAG-18 for Duchenne Muscular Dystrophy
NANTONG, China, Dec. 12, 2025 /PRNewswire/ -- Ractigen Therapeutics, a pioneering developer of small activating RNA (saRNA) therapeutics, today announced the successful dosing of the first patient in its investigator-initiated trial (IIT) of RAG-18...
EpiVax and FDA Scientists Publish New Insights on Immunogenicity Risks of Peptide-Related Impurities in Generic Teriparatide
PROVIDENCE, R.I., Dec. 9, 2025 /PRNewswire/ -- EpiVax, Inc., with U.S. Food and Drug Administration (FDA) and CUBRC, Inc. (Buffalo, NY) scientist collaborators, announces the publication of a study titled "Immunogenicity Risk Assessment of...
Great Place To Work® unveils the first Fortune 100 Best Companies to Work For™ Southeast Asia list, with Singapore's Capella Hotelsearning a place in the top three
Three Singapore-headquartered companies were recognized for workplace culture in the inaugural 2025 Fortune 100 Best Companies to Work For™ Southeast Asia list. Over 1.3 million employees from ten countries were invited to share their views. Placing...
Asia PGI and partners unveil preview of PathGen: new AI-powered outbreak intelligence tool
Asia-led, "sovereign-by-design" platform built for secure, decentralised pathogen intelligence-sharing across borders aims to break data silos and provide faster "time to actionable insight" of outbreaks, from detection to control measures being in...
EF English Proficiency Index 2025 launched: AI-Powered Insights Reveal Global Language Shifts in a Fragmented World
Skills gap widespread; gender gap narrowing; youth proficiency low ZURICH, Nov. 19, 2025 /PRNewswire/ -- EF (Education First), a global provider of culturally immersive education, released the 2025 edition of its EF English Proficiency Index (EF...
ArkBio Initiates Phase II Clinical Trial of AK0610, a Preventive Monoclonal Antibody for Respiratory Syncytial Virus Infection
SHANGHAI, Oct. 30, 2025 /PRNewswire/ -- Shanghai Ark Biopharmaceutical Co., Ltd. ("ArkBio") today announced the initiation of a Phase II clinical study of AK0610, a fully human monoclonal antibody designed to prevent respiratory syncytial virus...
New findings highlight gaps in how leaders assess high-potential talent
Time to swap subjectivity for structured talent assessment 91% of HR and 88% of leaders use subjective performance ratings Just 45% of HR and 30% of leaders use psychometric assessments 67% of high potential (HiPo) employees say identification has a...
ACM Biolabs Reports Favorable Safety Signals and Early Pharmacodynamics from Intramuscular Administration of ACM-CpG in Patients with Advanced Solid Tumors
SINGAPORE, Oct. 22, 2025 /PRNewswire/ -- ACM Biolabs, a clinical-stage biotechnology company developing next-generation nanoparticle-based immunotherapies, today announced encouraging early clinical findings from its ongoing Phase 1 study of...
Global Times: China's steady engagement a reassuring, constructive force in Central Asia, says Turkmen scholar
BEIJING, June 17, 2025 /PRNewswire/ -- Chinese President Xi Jinping will attend the second China-Central Asia Summit in Astana from June 16 to 18, where he and the leaders of the five Central Asian countries will weave tighter threads of trade,...